Suchergebnisse - "Xiao, Dunming"

PubPharm (15)

1

Real-world cost- effectiveness analysis : Tumor Treating Fields for newly diagnosed glioblastoma in China

enthalten in: Journal of neuro-oncology | 2024

von Xiang, Y. | Chen, Y. | Xu, Z. | +5

2

Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer : A Societal Perspective

enthalten in: Advances in therapy | 2024

von Li, F. | Chen, Y. | Xiao, D. | +2

3

Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective

enthalten in: Advances in therapy | 2024

von Li, F. | Chen, Y. | Xiao, D. | +2

4

Correction to : Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

enthalten in: Advances in therapy | 2022

von Xiao, D. | Zhang, Y. | Chen, W. | +2

ErratumFor: Adv Ther. 2022 Jun;39(6):2971-2983. - PMID 35488140

5

Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes

enthalten in: Postgraduate medicine | 2022

von Zhang, L. | Leng, X. | Tian, F. | +5

6

Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

enthalten in: Advances in therapy | 2022

von Xiao, D. | Zhang, Y. | Chen, W. | +2

7

Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

enthalten in: Advances in therapy | 2022

von Xiao, D. | Zhang, Y. | Chen, W. | +2

8

Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

enthalten in: Advances in therapy | 2022

von Xiao, D. | Zhang, Y. | Chen, W. | +2

9

Treatment and economic burden of mucormycosis in China : Case report review and burden estimation

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Jian, Y. | Wang, M. | Yu, Y. | +4

10

Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

enthalten in: Advances in therapy | 2022

von Xiao, D. | Zhang, Y. | Chen, W. | +2

ErratumIn: Adv Ther. 2022 Sep;39(9):4394-4396. - PMID 35900695